C12N 2740/11043
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2740/11043 (Viral genome or elements thereof as genetic vector) appears on 30 US grants and 29 published applications in this corpus.
Search patents in C12N- Granted patents
- 30
- Published applications
- 29
- Assignees
- 30
- Inventors
- 62
- Latest grant
- 24 Jan 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 0 |
| 2003 | 1 | 0 |
| 2004 | 1 | 3 |
| 2005 | 1 | 0 |
| 2006 | 1 | 6 |
| 2007 | 0 | 0 |
| 2008 | 2 | 1 |
| 2009 | 1 | 2 |
| 2010 | 1 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 2 |
| 2013 | 4 | 2 |
| 2014 | 2 | 4 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 2 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 3 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Lysosomal storage disease enzymes24 Jan 2023US 11,560,554 B2Alexion Pharmaceuticals, Inc.
- Lysosomal storage disease enzymes8 Dec 2020US 10,858,638 B2Alexion Pharmaceuticals, Inc.
- Lysosomal storage disease enzymes10 Sep 2019US 10,407,671 B2Alexion Pharmaceuticals, Inc.
- Method of using a transgenic chicken to produce exogenous proteins in its eggs22 Jan 2019US 10,182,561 B2Alexion Pharmaceuticals, Inc.
- Biological function effecting viral vectors and chimeric cells useful as packaging cell lines and target cells22 Apr 2014US 8,703,480 B1Enzo Therapeutics, Inc.
- Dual targeted gene therapy17 Sep 2026US 2026/0275377 A1Kelonia Therapeutics, Inc.
- Glycoproteins for pseudotyping retroviral vector particles25 Dec 2025US 2025/0388924 A1Medizinische Hochschule Hannover
- Alpharetrovirus-based particles for delivery of rna into cells30 Oct 2025US 2025/0333759 A1Medizinische Hochschule Hannover
- Compositions and methods for modifying eukaryotic cells18 Sep 2025US 2025/0290097 A1Orchard Therapeutics (Europe) Limited
- Lysosomal storage disease enzymes10 Jun 2021US 2021/0171922 A1Alexion Pharmaceuticals, Inc.
Most cited
By later US patents
- Method of gene transfer into chickens and other avian species102US 5,162,215 AAmgen Inc. · 1992
- Retroviral packaging cell lines77US 5,591,624 AChiron Viagene, Inc. · 1997
- Immunization by inoculation of DNA transcription unit50US 5,643,578 ASt. Jude Children?S Research Hospital · 1997
- Vectors in avian transgenesis37US 6,730,822 B1AviGenics, Inc. · 2004
- Packaging cells23US 5,716,832 AChiron Viagene, Inc. · 1998